Conscious Sedation Efficacy of the MKO Melt (Midazolam, Ketamine, Ondansetron)



Status:Completed
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:18 - Any
Updated:9/2/2018
Start Date:June 28, 2017
End Date:November 4, 2017

Use our guide to learn which trials are right for you!

Conscious Sedation Efficacy of the Novel Medication, MKO Melt (Midazolam, Ketamine, Ondansetron), During Cataract Surgery

The investigators hypothesized that the combination of Valium, Tramadol and Zofran is
superior to the substantially more expensive MKO melt in patient satisfaction after cataract
surgery.

The MKO melt is being marketed as an anesthetic medication for cataract surgery that has the
advantage that it eliminates the need for an IV in 85% of patients although that number was
established anecdotally. This alternative, however, is very cost limiting.The investigators
wanted to see if the current regimen (valium only) or a combination similar to the MKO melt
(valium + tramadol + zofran) are as good if not better than the MKO melt for anesthesia and
how many patients could have indeed gone with an intravenous line (didn't need any extra
medications).

Inclusion Criteria:

- All patients scheduled to undergo cataract surgery with Drs. Mayo and Wade at Kirby
Glen Surgery Center

Exclusion Criteria:

- Age <18 years

- Patient is not suitable for the medications for reasons such as unsteady gait, cane,
wheelchair, severe dementia (unable to consent), terminal illness

- Allergy to a medication in protocol
We found this trial at
1
site
?
mi
from
Houston, TX
Click here to add this to my saved trials